NOMD · Nomad Foods Ltd · Insider Trading

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged form $12.25 to $12.49, inclusive. The Reporting Person undertakes to provide the Issuer and will provide any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each separate price within the specified range.

Includes 150,000 Restricted Share Units which shall vest on the first anniversary of the grant date (November 3, 2025).

Includes 184,991 Restricted Share Units which will vest on June 17, 2027.

8,182 restricted stock units held by the reporting person vesting on June 22, 2026 and settled on July 2, 2026. The Issuer withheld the reported shares to cover the reporting person's tax liability associated with the vesting of these restricted stock units.

8,182 restricted stock units held by the reporting person vesting on June 22, 2026 and settled on July 2, 2026. The Issuer withheld the reported shares to cover the reporting person's tax liability associated with the vesting of these restricted stock units.

8,182 restricted stock units held by the reporting person vesting on June 22, 2026 and settled on July 2, 2026. The Issuer withheld the reported shares to cover the reporting person's tax liability associated with the vesting of these restricted stock units.

8,182 restricted stock units held by the reporting person vesting on June 22, 2026 and settled on July 2, 2026. The Issuer withheld the reported shares to cover the reporting person's tax liability associated with the vesting of these restricted stock units.

8,378 restricted stock units held by the reporting person vesting on June 22, 2026 and settled on July 2, 2026. The Issuer withheld the reported shares to cover the reporting person's tax liability associated with the vesting of these restricted stock units.

These shares were issued as a restricted share unit grant to the Reporting Person by the Issuer.

These Restricted Share Units shall vest on the earlier of (i) the date of the Issuer's 2027 annual meeting of shareholders or (ii) July 22, 2027.

These shares were issued as a restricted share unit grant to the Reporting Person by the Issuer.

These Restricted Share Units shall vest on the earlier of (i) the date of the Issuer's 2027 annual meeting of shareholders or (ii) July 22, 2027.

These shares were issued as a restricted share unit grant to the Reporting Person by the Issuer.

These Restricted Share Units shall vest on the earlier of (i) the date of the Issuer's 2027 annual meeting of shareholders or (ii) July 22, 2027.

These shares were issued as a restricted share unit grant to the Reporting Person by the Issuer.

These Restricted Share Units shall vest on the earlier of (i) the date of the Issuer's 2027 annual meeting of shareholders or (ii) July 22, 2027.

These shares were issued as a restricted share unit grant to the Reporting Person by the Issuer.

These Restricted Share Units shall vest on the earlier of (i) the date of the Issuer's 2027 annual meeting of shareholders or (ii) July 22, 2027.

This amount corrects an inadvertent administrative error in the Form 3 filed by the Reporting Person on March 17, 2026 in which the number of securities beneficially owned by the Reporting Person was under-reported by 196 restricted share units.

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged form $9.73 to $9.86, inclusive. The Reporting Person undertakes to provide the Issuer and will provide any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each separate price within the specified range.

Includes 150,000 Restricted Share Units which shall vest on the first anniversary of the grant date (November 3, 2025).

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged form $9.56 to $9.7209, inclusive. The Reporting Person undertakes to provide the Issuer and will provide any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each separate price within the specified range.

Includes 184,991 Restricted Share Units which will vest on June 17, 2027.

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged form $9.1167 to $9.1878, inclusive. The Reporting Person undertakes to provide the Issuer and will provide any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each separate price within the specified range.

These shares are held directly by the Ian G.H. Ashken Living Trust, of which the Reporting Person is the sole settlor and trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $9.11 to $9.32, inclusive. The Reporting Person undertakes to provide the Issuer and will provide any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each separate price within the specified range.

These shares are held indirectly by TOMS Capital Investments LLC, a Delaware limited liability company through a wholly-owned subsidiary. The Reporting Person controls, and indirectly owns, 100% of TOMS Capital Investments LLC's interests in these shares. The Reporting Person disclaims beneficial ownership of such shares to the extent of his pecuniary interest therein.

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $9.48 to $9.655, inclusive. The Reporting Person undertakes to provide the Issuer and will provide any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each separate price within the specified range.

These shares are held indirectly by TOMS Capital Investments LLC, a Delaware limited liability company through a wholly-owned subsidiary. The Reporting Person controls, and indirectly owns, 100% of TOMS Capital Investments LLC's interests in these shares. The Reporting Person disclaims beneficial ownership of such shares to the extent of his pecuniary interest therein.

Subject to (i) the Reporting Person satisfying the share purchase component under the Issuer's Co-Investment and Share Option Matching Sub Plan (the "Sub Plan") between May 5, 2025 and June 5, 2027 and (ii) the Issuer's achievement of the share price performance target during the period beginning May 7, 2026 and ending on May 7, 2031 (the "Performance Period"), the Options will vest and become exercisable, if at all, on the later of (x) May 7, 2029 and (y) the achievement of the specified share price performance target during the Performance Period.

Subject to (i) the Reporting Person satisfying the share purchase component under the Issuer's Co-Investment and Share Option Matching Sub Plan (the "Sub Plan") between May 5, 2025 and June 5, 2027 and (ii) the Issuer's achievement of the share price performance target during the period beginning May 7, 2026 and ending on May 7, 2031 (the "Performance Period"), the Options will vest and become exercisable, if at all, on the later of (x) May 7, 2029 and (y) the achievement of the specified share price performance target during the Performance Period.

Subject to (i) the Reporting Person satisfying the share purchase component under the Issuer's Co-Investment and Share Option Matching Sub Plan (the "Sub Plan") between May 5, 2025 and June 5, 2027 and (ii) the Issuer's achievement of certain share price performance targets during the period beginning May 7, 2026 and ending on May 7, 2031 (the "Performance Period"), the Options will vest and become exercisable, if at all, on the later of (x) May 7, 2029 and (y) the achievement of the specified share price performance targets during the Performance Period.

The number of options set forth herein represents the maximum number of options that are eligible to vest under the option agreement if the Issuer achieves the maximum specified share price performance target during the Performance Period and such number of options eligible to vest will be reduced to 87.5%, 75%, 50%, 20% or 0% of the number of options reported herein to the extent that the Issuer achieves one or more lower specified share price performance targets during the Performance Period.

Subject to (i) the Reporting Person satisfying the share purchase component under the Issuer's Co-Investment and Share Option Matching Sub Plan (the "Sub Plan") between May 5, 2025 and June 5, 2027 and (ii) the Issuer's achievement of certain share price performance targets during the period beginning May 7, 2026 and ending on May 7, 2031 (the "Performance Period"), the Options will vest and become exercisable, if at all, on the later of (x) May 7, 2029 and (y) the achievement of the specified share price performance targets during the Performance Period.

The number of options set forth herein represents the maximum number of options that are eligible to vest under the option agreement if the Issuer achieves the maximum specified share price performance target during the Performance Period and such number of options eligible to vest will be reduced to 87.5%, 75%, 50%, 20% or 0% of the number of options reported herein to the extent that the Issuer achieves one or more lower specified share price performance targets during the Performance Period.

220,000 shares previously reported as held indirectly by RSMA, LLC, of which Mr. Franklin is the managing member, were transferred to the Martin E. Franklin Revocable Trust (the "Franklin Trust") for estate planning purposes.

These Ordinary Shares are held by directly by RSMA, LLC, of which Mr. Franklin is the managing member. Mr. Franklin disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.

220,000 shares previously reported as held indirectly by RSMA, LLC, of which Mr. Franklin is the managing member, were transferred to the Martin E. Franklin Revocable Trust (the "Franklin Trust") for estate planning purposes.

These Ordinary Shares are held by the Martin E. Franklin Revocable Trust, of which Mr. Franklin is the sole settlor, trustee and beneficiary. Mr. Franklin disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.